Aravive, Inc. Common Stock
ARAV
ARAV was delisted on the 26th of January, 2024.
35 hedge funds and large institutions have $21.5M invested in Aravive, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 8 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
3% less funds holding
Funds holding: 36 → 35 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
42% less capital invested
Capital invested by funds: $36.9M → $21.5M (-$15.4M)
86% less call options, than puts
Call options by funds: $198K | Put options by funds: $1.38M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$206K |
| 2 |
BlackRock
New York
|
+$182K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$174K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$144K |
| 5 |
Renaissance Technologies
New York
|
+$99.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.71M |
| 2 |
Millennium Management
New York
|
-$415K |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$292K |
| 4 |
Two Sigma Advisers
New York
|
-$228K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$213K |
ARAV Hedge Fund Activity: Q2 2023 in Review
35 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Aravive, Inc. Common Stock (ARAV) for Q2 2023, worth a combined $21.5M — down 42% from $36.9M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ARAV and 7 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 8 added.
The largest buyer was HRT Financial, opening a new position worth an estimated $206K. The largest seller was Vanguard Group, cutting an estimated $1.71M.
- 35 institutional investors held Aravive, Inc. Common Stock (ARAV) as of Q2 2023, down from 36 in Q1 2023.
- Funds reported $21.5M of Aravive, Inc. Common Stock stock for Q2 2023, down 42% quarter-over-quarter.
- 7 funds opened new Aravive, Inc. Common Stock positions in Q2 2023 and 8 closed out, a net change of -1 holder.
- The largest Aravive, Inc. Common Stock buyer in Q2 2023 was HRT Financial, an estimated $206K added.
- The largest Aravive, Inc. Common Stock seller in Q2 2023 was Vanguard Group, an estimated $1.71M sold.
Based on aggregated 13F filings for Q2 2023.